Program 03
Systemic Signal Detection
Can upstream biological changes—metabolic stress, immune restraint failure, tissue remodeling—be detected before tumors develop?
Why This Program
The premise behind Program 03.
If breast cancer in young women is driven by upstream biological factors, the next critical question is whether these early indicators can be identified before tumors develop. Current early-detection approaches focus on detecting established lesions, designed to pick up tumor signals that may be absent or very weak in early-stage disease.
This program is built on a different premise: before tumors become visible, the body may already show detectable signs of changed biology—mitochondrial stress responses, variations in immune energetics, inflammatory status, and tissue remodeling.
What We Mean
Defining systemic signal detection.
In this context, systemic detection refers to measuring blood- and body fluid–accessible signals that reflect upstream tissue states.
- Stress and damage signatures — Mitochondrial and metabolic stress responses detectable in circulation, reflecting upstream tissue-level disruption.
- Immune energetics and metabolic–inflammation coupling — Shifts in immune fitness, suppression, and systemic metabolic–inflammation crosstalk that reflect early biological change.
- Spillover signals from tissue disruption — Markers of extracellular matrix remodeling and tissue-level disturbance—biologically grounded, mechanistically linked, and actionable.
Rather than detecting tumors directly, this approach identifies the biological consequences of early disease—enabling detection of risk and early progression before structural changes become visible.